This experiment examined the effects of nitric oxide (NO) synthase inhibition on brain intracellular pH, regional cortical blood flow, and NADH fluorescence be fore and during 3 h of focal cerebral ischemia using in vivo fluorescence imaging. Thirty fasted rabbits under 1% halothane were divided into four treatment groups receiv ing NW-nitro-L-arginine methyl ester (L-NAME) intrave nously at 20 min prior to ischemia (0. I, I, and 10 mg/kg and 1 mg/kg + 5 mg/kg L-arginine) and two control groups (nonischemic and ischemic). In ischemic controls, brain pHj declined to 6.73 ± 0.03 at 30 min and remained acidotic through the remainder of the ischemic period. In the 0. 1 mg/kg group, brain pHj fell after 30 min of isch Abbreviations used: ANOV A, analysis of variance; BBB, blood-brain barrier; CBF, cerebral blood flow; CNS, central ner vous system; GADPH, glyceraldehyde-3-phosphate dehydroge nase; L-NAME, N'"-nitro-L-arginine methyl ester; MCA, middle cerebral artery; NO, nitric oxide; NOS, nitric oxide synthase; PARS, poly (adenosine 5'-diphosphoribose) synthatase.
emia to 6.76 ± 0.05 (p < 0.05), but then improved pro gressively despite occlusion. In the I mg/kg group, brain pHj remained normal despite middle cerebral artery (MeA) occlusion. In the 10 mg/kg group and in the com-Emerging evidence suggests that nitric oxide (NO) may play a role in ischemic brain injury (Huang et aI., 1994) . Direct measurements have shown a large increase in NO during focal cerebral ischemia (Malinski et aI., 1993) . However, the role and mechanisms of NO-mediated neurotoxicity re main speculative. During ischemia, release of excit atory amino aicds activates N-methyl-D-aspartate (NMDA) receptors producing a calcium transient. This enhances NO production by activating nitric oxide synthase (NOS), which is calcium-dependent (Dugan and Choi, 1994) . Dawson et al. (1991) ob served that NMDA-mediated neuronal injury could be blocked by inhibition of NO production. The ef fects of NOS inhibition during brain ischemia in vivo remain controversial, with some groups reporting protective (Nowicki et aI., 1991; Ashwal et aI., 1994; Nishikawa et aI., 1994) and some reporting toxic (Zhang and Iadecola, 1994; Yamamoto et aI., 1992; Kuluz et aI., 1993) effects. This controversy may reflect the fact that in vivo nonselective inhi bition of endothelial and neuronal NOS may pro duce opposite effects on neuronal injury.
The purpose of this experiment was to examine the effects of NOS inhibition by W-nitro-L-arginine methyl ester (L-NAME), administered prior to focal cerebral ischemia, on serial changes in intracellular brain pH (pH;), regional cortical blood flow, and the nicotinamide adenine dinucleotide (NADH) redox state as measured by in vivo fluorescence imaging (Anderson et aI. , 1992) . We also tested if coadmin istration of L-NAME and L-arginine could reverse any effect produced by L-NAME.
MATERIALS AND METHODS

Animal preparation
Upon approval from the Animal Care and Use Com mittee, 30 overnight-fasted New Zealand white rabbits, weighing 3.5-4.5 kg, were induced with thiamytal sodium 40 mg/kg (Surital), and operated on at 2.0% and studied under 1.0% halothane anesthesia, respectively. A trache otomy was performed, and animals were placed on a Har vard respirator (Harvard Apparatus, Millis, MA, U.S.A.). Animals were given 0.15 mg/kg pancuronium bromide (Pavulon) (Organon Inc, West Orange, NJ, U.S.A.) to abolish respiratory efforts. Animals were kept normoxic and normocarbic during the surgical procedure and throughout the experimental procedure with supple mental CO2 and O2, Catheters were inserted into the right femoral artery and vein for monitoring blood pressure, sampling arterial blood gases, and administration of drugs. A PE-50 cath eter was inserted into the right lingual artery so that its tip was located at the origin of the external carotid artery for retrograde delivery of the indicator umbelliferone into the internal carotid artery.
Skin, subcutaneous tissue, and muscle were excised over the right supraorbital ridge and parietal area. A craniectomy was performed utilizing a high speed air drill (Hall Surgical, Division of Zimmer, Santa Barbara, CA, U.S.A.) with the aid of an Olympus operating microscope (Olympus, Tokyo, Japan). The majority of the frontal and parietal cortex was exposed for imaging. The dura was removed and carefully cauterized at the margins of the craniectomy, then covered with Saran Wrap to prevent surface oxygenation and to keep the brain moist. Blood loss for surgical preparation was not >5 ml.
Following surgical preparation, the animal was moved from the operating table and placed on an intravital-type microscope stand. The microscope was focused on an area centered about the suprasylvian gyrus, with 1.5 cm 2 of cortex imaged for pHj, regional cortical blood flow and NADH fluorescence measurements. Arterial blood pres sure was measured by a Statham strain gauge (Statham, Oxnard, CA, U.S.A.) attached to the femoral artery cath eter and recorded on a Grass model 78 polygraph. Ani mals were kept normothermic by the use of a heating blanket (K-Pad, Gorman-Rupp, Bellville, OH, U.S.A.) and core body temperature was monitored with a rectal digital thermometer. Arterial Paco2, P,.o2' and pHa mea surements were performed on a London Radiometer blood gas analyzer (PHM-73) (Copenhagen, Denmark). Brain temperature was not measured in this study since earlier infrared microscopy studies in this laboratory had shown only small decreases « I.SOC) in brain tempera ture during focal cerebral ischemia in the squirrel monkey (Sundt et aI., 1976) . It is known that brain tissue is a poor conductor of thermal activity. Therefore, in a model of focal cerebral ischemia, in which small volumes of tissue are affected, there would be small variations in brain tem perature compared with that of global ischemia.
Focal cerebral ischemia was induced by occlusion of the middle (MCA) and anterior (ACA) cerebral arteries using Mayfield miniature aneurysm clips. The contralat eral common carotid artery was also ligated. Animals were studied over a period of 180 min offocal ischemia. Thirty rabbits were divided into six groups of five each. There was a nonischemic control group and an ischemic control group, and four drug groups that received O. I, I, 10 mg/kg L-NAME, or I mg/kg L-NAME with simulta neous administration of 5 mg/kg L-arginine. Drugs were administered intravenously at a rate of I ml/min for 5 min at 20 min prior to the onset of ischemia.
In vivo video fluorescent instrumentation
Instrumentation was designed to perform serial pan oramic video imaging of cortical brain pHj and regional cortical blood flow with umbelliferone fluorescence (Anderson et aI., 1992) . The optical characteristics were such that the majority of the entire hemisphere could be studied simultaneously through a large craniectomy. The use of umbelliferone as a noninvasive in vivo technique for measuring brain pHj and cortical blood flow has been previously described (Anderson et aI., 1992; Anderson et aI., 1987) . Umbelliferone is nontoxic, fat-soluble, and freely diffusible across the blood-brain barrier (BBB), it is equilibrated rapidly across cell membranes and is distrib uted through the cytoplasm as an uncharged molecule (Anderson et aI., 1992) . U mbelliferone was prepared for injection by dissolving 0.2 g of indicator in 200 ml of 5% glucose-saline solution at 90°C for 30 min. The solution was then filtered through a 0.22 mesh filter before injec tion. The volume of injectate was 1.5 ml in this study.
The pH-sensitive indicator umbelliferone has two fluo rophors, anionic and isobestic, that are excited at 370 and 340 nm, respectively, and have a common emission at 450 nm. Fluorescence of the anionic form varies directly with pH, whereas fluorescence of the isobestic form varies directly only with indicator concentration. Therefore, it is possible to create a nomogram from the ratio of 340-nm: 370-nm excitations to determine brain pHj' Acquired im ages were corrected for background NADH fluorescence before processing. NADH fluorescence images were stored for later analysis of mitochondrial function. Im ages from the 340-nm excitation were processed to com pute regional cortical blood flow using the I-min initial slope index. The regional cortical blood flow image was then displayed and stored on tape for final analysis. For processing of the pHj image, ratios of the paired images from the 340-nm:370-nm excitations were made, and the resultant pHj image was then displayed and stored on tape for final analysis. Umbelliferone has been shown to be a reliable indicator of cortical blood flow. Anderson et aI., (1987) compared the different techniques of measur ing cerebral blood flow (CBF) to that of umbelliferone. They found that a distinction can be made between cere bral blood flow (CBF), as measured by radiolabeled com pounds, and cortical blood flow, as measured by umbel liferone. CBF, by definition, indicates areas of flow that contain major vessels as well as capillaries and arterioles, as measured by radiolabeled compounds. Cortical blood flow, as measured by umbelliferone, indicates areas that are relatively avascular and contain primarily arterioles and capillary beds. The imaging system allows the mea surement of regional cortical blood flow by allowing the investigator to outline cortical areas of interest that are devoid of major surface conducting vessels. 
Min
State 
Statistical analysis
Because of anatomical variation of the microvascula ture from animal to animal, single points along an x,y coordinates cannot be averaged, frame by frame, from different animals for the same time period. Therefore, measurements of regional pHi' regional cortical blood flow-umbellife.rone, and NADH fluorescence were made in areas devoid of major vessels. Measurements of these parameters were made over these relatively avascular ar eas by averaging 10,000-15,000 pixels and the mean and standard deviation tabulated. Analysis of variance (ANOY A), followed by Newman-Keul's test for multiple comparisons were used to test the statistical significance of differences between groups. A p value of <0.05 was considered significant.
RESULTS
There were no significant differences over time between animals studied in each of the six groups in the measurements of Pac02, Pa02, body tempera ture, glucose, lactate, and hematocrit (Table 1) . Mean arterial blood pressure (MABP) increased af ter L-NAME administration and this was dose dependent (p < 0.05 at 10 mg/kg, Table 1 ).
Intracellular brain pH
Baseline brain pH; (Fig. 1) was uniform over the entire exposed cortex in all groups, measuring 6.99 ± 0.02. In the nonischemic control group, brain pH; remained stable throughout the experimental proto col and was 7.00 ± 0.03 after 240 min. During oc-elusion, pH; fell significantly (p < 0.05) in the isch emic-control group and was 6.73 ± 0.03 after 30 min of focal ischemia and did not recover after 180 min (6. 77 ± 0.04). Drug treatment with either L-NAME or L-NAME + L-arginine did not affect preocclu sion brain pH;. In the 0. 1 mg/kg L-NAME group, pH; fell significantly from a baseline of 7.01 ± 0. 02 to 6. 76 ± 0. 05 (p < 0. 05) at 30 min. At 60 min, pH; was still acidic (6.79 ± 0.05, p < 0.05), but then steadily improved towards normalization, measur ing 6. 87 ± 0.04 at 120 min and 6. 93 ± 0.07 at 180 min. In the 1 mg/kg L-NAME group, brain pHi re mained normal throughout the whole experimental protocol including the period of focal ischemia (6.99 ± 0.03 at 30 min; 6. 97 ± 0.04 at 60 min, and 6. 98 ± 0.04 at 180 min). These improvements in brain pH; were not associated with regional cortical blood flow changes, as discussed below. In the 10 mg/kg L-NAME group, pH; decreased significantly to 6.81 ± 0.03 after 30 min of focal ischemia. Similarly, pH; fell to 6.81 ± 0. 03 (p < 0. 05) after 30 min of isch emia in the combined L-NAME + L-arginine group. Both of these groups showed persistent and signif icant intracellular acidosis for the remainder of the ischemic period (6.75 ± 0.05 at 60 min, 6.75 ± 0.05 at 120 min, and 6. 77 ± 0. 06 at 180 min for the 10 mg/kg L-NAME group, and 6.79 ± 0.03 at 60 min, 6. 78 ± 0. 03 at 120 min, and 6.84 ± 0.04 at 180 min for the mixed L-NAME + L-arginine group).
Systemic parameters"
P0 2 Glucose Regional cortical blood flow
Regional cortical blood flow (Fig. 2) was stable (49.6 ± 2.8 ml/IOO g/min) throughout the experi mental protocol in the nonischemic control group. In the ischemic control group, baseline regional cor tical blood flow measured 49.9 ± 1. 5 ml/100 g/min. Regional cortical blood flow fell significantly (p < 0.05) to 28. 7 ± 3.7 ml/l00 g/min after 30 min of occlusion and remained near this level for the re mainder of the ischemic event, being significantly different from nonischemic control values. Baseline regional cortical blood flow was 52. 2 ± 5 ml/lOO g/min in the four drug treatment groups. At 5 and 20 min after drug infusion, regional cortical blood flow was not different from control values in the 0.1 and I mg/kg L-NAME and the L-NAME + L-arginine groups. In the 10 mg/kg L-NAME group, there was a 30% decrease in regional cortical blood flow after drug infusion that was significant at 20 min (38. 2 ± 5. 8 ml/IOO g/min, p < 0.05). During occlusion, re gional cortical blood flow decreased in a dose dependent manner. After 3 h of ischemia, regional cortical blood flow was 33.9 ± 10.9 and 25.1 ± 8. 9 ml/l00 g/min at doses of 0. 1 and 10. 0 mg/kg, respec tively.
NADH fluorescence NADH fluorescence measured over the exposed cortex remained stable throughout the experimental protocol in nonischemic control animals. NADH fluorescence was not affected by drug treatment, and values after infusion did not differ from control values. Thirty minutes after ischemia, NADH fluo rescence increased in the ischemic control group by 155 ± 12% (p < 0.05) and still measured 143 ± 9% (p < 0. 05) after 180 min of occlusion. A similar massive increase in ischemic NADH fluorescence was recorded in the L-NAME + L-arginine group: 149 ± 5% at 30 min and 146 ± 10% at 180 min of focal ischemia. All three L-NAME treatment groups showed an increase in NADH fluorescence (-141 ± 7% at 30 min and 122 ± 8% at 180 min). The percent increase was smaller than in ischemic con trol and L-NAME + L-arginine groups, but was not statistically different.
DISCUSSION
This study examined the effects of NOS inhibi tion by L-NAME on brain pHi' regional cortical blood flow, and NADH fluorescence during focal cerebral ischemia in vivo. The most consistent ob servation was that intravenous administration of low dose L-NAME prior to occlusion prevented in tracellular brain acidosis during focal cerebral isch emia. This effect was not related to regional cortical blood flow changes since blood flow decreased to the same extent during ischemia in all groups. Co administration of L-NAME and L-arginine abol ished the protective effect on brain acidosis, which 1. Bar graph showing intracellular brain pH (pHi) of the six study groups (n = 5 in each group) throughout the experimental protocol. Focal cerebral ischemia was produced by MeA occlusion at time 0 and maintained for 180 min. Drug administration did not affect pHi' The 1 mg/kg L-NAME ischemic group did not develop acidosis during focal cerebral ischemia, and pHi was not different from that of nonischemic controls throughout the experimental protocol. The 0.1 mg/kg L-NAME ischemic group showed early significant acidosis that recovered steadily after the 60 min time frame. Ischemic controls, the 10 mg/kg L-NAME, and the 1 mg/kg L-NAME + 5 mg/kg L-arginine ischemic groups all showed early significant acidosis during focal ischemia that did not recover during the 180 min of observation. Values are mean ± SO, * indicates p < 0.05.
suggests that the mediator was NOS. Administra tion of high dose L-NAME (10 mg/kg) decreased regional cortical blood flow prior to occlusion and ischemic brain acidosis was not prevented in this group. Nitric oxide is increasingly being recognized as a major regulator of central nervous system (CNS) function. In the CNS, NO can originate from the endothelial cells of the cerebral vessels and from NOS containing neurons (Bredt and Snyder, 1994; Bruhwyler et aI. , 1993) and plays a role in CBF regulation (ladecola et aI., 1994) . Neuronal NOS is a constitutive enzyme that is activated by Ca 2 + (Bredt and Snyder, 1990) , and has been shown to be coupled primarily to activation of the NMDA receptor (Dawson et aI., 1993) . NO is synthesized from L-arginine by NOS, which is competitively in hibited by L-NAME (Rees et aI., 1990) . Dawson et J Cereb Blood Flow Metab, Vol. 16, No.5, 1996 aI., (1991) showed that NMDA toxicity was blocked by NOS inhibitors in vitro. NO measurements in vivo have demonstrated that NO increases signifi cantly during focal cerebral ischemia (Malinski et aI., 1993) . Reports on the effects of NO in ischemic neuronal injury in vivo have been contradictory. Inhibition of NO synthesis has been shown, in some laboratories, to enhance injury (Zhang and Iade cola, 1994; Yamamoto et aI. , 1992; Kuluz et aI., 1993) or to provide substantial protection (Nowicki et aI., 1991; Ashwal et aI., 1994; Nishikawa et aI., 1994) . Nonselective inhibition of vascular and neu ronal isoforms could mask a neuroprotective effect evoked by selective neuronal NOS inhibition. A re cent study by Huang et aI. , (1994) , using mice de ficient in neuronal NOS (thus avoiding this dual ac tion of NO), provides substantial evidence that lack of neuronal NOS activity is associated with reduced hibition might decrease intracellular pH during fo cal cerebral ischemia include DNA damage by deamination (Nguygen et aI. , 1992) , free radical mediated production of peroxynitrite anions (ONOO-) (Beckman and Crow, 1993; Lipton et aI. , 1993) , S-nitrosylation of proteins, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) inhibition (Zhang and Snyder, 1992; McDonald and Moss, 1993) , and formation of NO-iron complexes with several enzymes including complexes I and II of the mitochondrial electron transport (Weiss et aI., 1993) . NO, like other free radicals, can damage DNA by base deamination (Nguyen et aI. , 1992; Wink et aI., 1991) . Zhang et aI. , (1994) demonstrated that NO activates poly(adenosine 5' -diphosphoribose) syn thetase (PARS) in association with damage to DNA, and that PARS inhibitors prevent NMDA neurotoxicity with relative potencies paralleling their inhibition of the enzyme. This enzyme activa tion can lead to cell death associated with depletion of ATP and a change in the NAD+/NADH redox state (Gaal et aI., 1987) . Inhibition of NOS during ischemia should retard this pathway and decrease consumption of both ATP and oxidized NAD+. An increase in ATP availability during ischemia cer tainly favors cell function, including pHi regulation involving the Na+/H+ exchanger and the HCO-3/ CI-transporter, which are energy-dependent. In addition, lack of PARS activation should decrease cellular consumption of NAD+ and reduce the drive for NADH regeneration coupled to lactic acid synthesis.
Free radical-mediated damage is another key common pathway of injury (Siesjo et aI. , 1989) . When NO reacts with superoxide anions (0 -2) it forms peroxynitrite anions (ONOO-) (Beckman and Crow, 1993; Lipton et aI., 1993) . These decom pose to yield highly damaging hydroxyl free radi cals, which have been suggested to initiate lipid per oxidation (Watson, 1993) . In addition to producing active metabolites, peroxidation may alter cell membrane fluidity (Thaw et aI., 1983) , with poten tial detrimental effects on membrane associated H + transporter and antiporter involved in brain pHi reg ulation. Lei et al. (1992) , showed that NO may be neuroprotective against NMDA toxicity, while oth ers have shown no neuroprotective effects (Regan et aI., 1993; Pauwels and Leysen, 1992) . NO may exert both neurodestructive and neuroprotective ef fects, depending on its oxidation-reduction status, with NO-being neurodestructive and NO+ being neuroprotective (Lipton et aI., 1993) .
Another possible mechanism is the stimulation by NO of the S-nitrosylation of various proteins (Lip-J Cereb Blood Flow Metab, Vol. 16, No.5, 1996 ton et aI., 1993 . NO can also modify GADPH, an important enzyme of glycolysis (McDonald and Moss, 1993) . Inhibition of GAPDH will also sup press lactate formation and could reduce brain tis sue acidosis (Hillered et aI., 1985) . NO has also been reported to inhibit iron-sulfur enzymes of the citric acid cycle and respiratory chain (Weiss et aI., 1993) . Improved respiratory metabolism and NOS inhibition should decrease intracellular acidosis during focal ischemia.
In conclusion, this study demonstrates that NOS inhibition by L-NAME prevents intracellular acido sis during focal cerebral ischemia independent from regional cortical blood flow changes. This observa tion has not been reported before, but based on this study, we postulate that brain acidosis may reflect NO-mediated neurotoxicity during focal ischemia. The multiplicity of actions attributed to NO in the CNS complicate studies in in vivo ischemia models. The molecular mechanisms by which L-NAME pre vents acidosis during focal ischemia remain uncer tain, but further exploration of pHi modulation by NO during focal cerebral ischemia may help better understand the complex pathways of ischemic neu ronal iI1iury.
